Dr. Andrew Chang, MD

• General Surgery

• Cardiothoracic Surgery

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Johns Hopkins University / School Of Radiologic Technology

  Medical School, 1993

• MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer, 2015-06-19

• Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis, 2019-05-17

• Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett's Esophagus, 2020-06-09

• Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model, 2014-12-01

• Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early Stage Lung Cancers, 2017-07-17

• Silencing of long non-coding RNA MIR22HG triggers cell survival/death signaling via oncogenes YBX1, MET, and p21 in lung cancer, 2018-04-18

• Paired Exome Analysis of Barrett's Esophagus and Adenocarcinoma, 2015-07-20

• Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma, 2015-06-01

• Early oral feeding following McKeown minimally invasive esophagectomy: an open-label, randomized, controlled, non-inferiority trial, 2018-04-13

• A lower tidal volume regimen during one lung ventilation for lung resection surgery is not associated with reduced postoperative pulmonary complications, 2021-04-01

• IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma, 2015-07-17

• Multi-Site Observational Study to Assess Biomarkers for Susceptibility or Resilience to Chronic Pain: The Acute to Chronic Pain Signatures (A2CPS) Study Protocol, 2022-04-25

• Overexpression ofLINC00152correlates with poor patient survival and knockdown impairs cell proliferation in lung cancer, 2017-06-07

• 18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer, 2018-07-02

• Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage, 2018-12-19

• Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer, 2016-02-05

• Overexpression ofFAM83H-AS1indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer, 2017-02-15

• Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer, 2012-07-31

• Immune determinants of Barrett's progression to esophageal adenocarcinoma, 2021-01-11

• Morphomic factors associated with complete response to neoadjuvant therapy in esophageal carcinoma, 2019-09-21

• Clinical impact of routine esophagram after peroral endoscopic myotomy, 2020-06-03

• Proanthocyanidins mitigate bile acid-induced changes in GSTT2 levels in a panel of racially diverse patient-derived primary esophageal cell cultures, 2021-11-10

• Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells, 2019-11-09

• Somatic mutations affect key pathways in lung adenocarcinoma, 2008-10-23

• Gene Expression-Based Survival Prediction in Lung Adenocarcinoma: A Multi-Site, Blinded Validation Study Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, 2008-07-20

• TGM2 A Cell Surface Marker in Esophageal Adenocarcinomas, 2014-08-19